222 related articles for article (PubMed ID: 26002590)
21. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes.
Kelly CB; Yu JY; Jenkins AJ; Nankervis AJ; Hanssen KF; Garg SK; Scardo JA; Basu A; Hammad SM; Aston CE; Lyons TJ
J Clin Endocrinol Metab; 2019 Oct; 104(10):4743-4755. PubMed ID: 31219590
[TBL] [Abstract][Full Text] [Related]
22. Vitamin E Intake Is Associated with Lower Brain Volume in Haptoglobin 1-1 Elderly with Type 2 Diabetes.
Livny A; Schnaider Beeri M; Heymann A; Moshier E; Berman Y; Mamistalov M; Shahar DR; Tsarfaty G; Leroith D; Preiss R; Soleimani L; Silverman JM; Bendlin BB; Levy A; Ravona-Springer R
J Alzheimers Dis; 2020; 74(2):649-658. PubMed ID: 32065799
[TBL] [Abstract][Full Text] [Related]
23. Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes.
Astley S; Langrish-Smith A; Southon S; Sampson M
Diabetes Care; 1999 Oct; 22(10):1626-31. PubMed ID: 10526726
[TBL] [Abstract][Full Text] [Related]
24. Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?
Vardi M; Levy AP
Curr Diab Rep; 2012 Jun; 12(3):274-9. PubMed ID: 22427005
[TBL] [Abstract][Full Text] [Related]
25. Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes.
Simpson M; Snell-Bergeon JK; Kinney GL; Lache O; Miller-Lotan R; Anbinder Y; Rewers MJ; Levy AP
Cardiovasc Diabetol; 2011 Nov; 10():99. PubMed ID: 22098782
[TBL] [Abstract][Full Text] [Related]
26. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
27. Changes in serum afamin and vitamin E levels after selective LDL apheresis.
Varga VE; Lőrincz H; Szentpéteri A; Juhász L; Seres I; Paragh G; Balla J; Paragh G; Harangi M
J Clin Apher; 2018 Oct; 33(5):569-575. PubMed ID: 30247793
[TBL] [Abstract][Full Text] [Related]
28. Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.
Banini BA; Cazanave SC; Yates KP; Asgharpour A; Vincent R; Mirshahi F; Le P; Contos MJ; Tonascia J; Chalasani NP; Kowdley KV; McCullough AJ; Behling CA; Schwimmer JB; Lavine JE; Sanyal AJ;
J Clin Gastroenterol; 2019; 53(10):750-758. PubMed ID: 30586008
[TBL] [Abstract][Full Text] [Related]
29. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Ward NC; Wu JH; Clarke MW; Puddey IB; Burke V; Croft KD; Hodgson JM
J Hypertens; 2007 Jan; 25(1):227-34. PubMed ID: 17143195
[TBL] [Abstract][Full Text] [Related]
30. Haptoglobin phenotype, pre-eclampsia, and response to supplementation with vitamins C and E in pregnant women with type-1 diabetes.
Weissgerber TL; Gandley RE; Roberts JM; Patterson CC; Holmes VA; Young IS; McCance DR;
BJOG; 2013 Sep; 120(10):1192-9. PubMed ID: 23718253
[TBL] [Abstract][Full Text] [Related]
31. Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables.
Braeckman L; De Bacquer D; Delanghe J; Claeys L; De Backer G
Atherosclerosis; 1999 Apr; 143(2):383-8. PubMed ID: 10217368
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Lipoprotein Subfractions in 920 Patients With and Without Type 2 Diabetes.
Zhao X; Zhang HW; Zhang Y; Li S; Xu RX; Sun J; Zhu CG; Wu NQ; Gao Y; Guo YL; Liu G; Dong Q; Li JJ
Heart Lung Circ; 2017 Mar; 26(3):211-218. PubMed ID: 28027866
[TBL] [Abstract][Full Text] [Related]
33. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.
Vardi M; Blum S; Levy AP
Eur J Intern Med; 2012 Oct; 23(7):628-32. PubMed ID: 22939808
[TBL] [Abstract][Full Text] [Related]
34. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
[TBL] [Abstract][Full Text] [Related]
35. Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population.
Weissgerber TL; Gandley RE; McGee PL; Spong CY; Myatt L; Leveno KJ; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Samuels P; Sciscione A; Harper M; Tolosa JE; Saade G; Sorokin Y;
PLoS One; 2013; 8(4):e60479. PubMed ID: 23573260
[TBL] [Abstract][Full Text] [Related]
36. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.
Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z
J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970
[TBL] [Abstract][Full Text] [Related]
37. Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes.
Engelen W; Keenoy BM; Vertommen J; De Leeuw I
Am J Clin Nutr; 2000 Nov; 72(5):1142-9. PubMed ID: 11063441
[TBL] [Abstract][Full Text] [Related]
38. The effect of supplementation with an antioxidant preparation on LDL-oxidation is determined by haptoglobin polymorphism.
Bernard D; Christophe A; Delanghe J; Langlois M; De Buyzere M; Comhaire F
Redox Rep; 2003; 8(1):41-6. PubMed ID: 12631443
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
[TBL] [Abstract][Full Text] [Related]
40. Haptoglobin genotype is associated with increased endothelial dysfunction serum markers in type 1 diabetes.
Llauradó G; Gutiérrez C; Giménez-Palop O; Cano A; Pareja R; Berlanga Escalera E; González-Sastre M; Vendrell J; González-Clemente JM
Eur J Clin Invest; 2015 Sep; 45(9):932-9. PubMed ID: 26122942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
